SCHEMBL823632

SCHEMBL823632

CCOc1nc(N)nc2ccc(-c3ccc(NC(=O)C4(N)CC4)cc3)nc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
MAPT P10636 7/20 0.35
TEK Q02763 4/20 0.35
KDR P35968 2/20 0.35
EPHB4 P54760 2/20 0.35
KDM4E B2RXH2 2/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ROCK2 O75116 2/20 0.34
ALDH1A1 P00352 2/20 0.34
RXFP1 Q9HBX9 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
CNR2 P34972 1/20 0.34
POLB P06746 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL823706 0.90 PDE4A (0.38) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL4522465 0.86 MEN1 (0.46) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL823737 0.85 PDE4A (0.34) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL823746 0.85 PDE4A (0.38) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL823755 0.85 PDE4A (0.41) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL823749 0.85 NPC1 (0.45) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL823805 0.83 RAB9A (0.45) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL14131735 0.83 CTNNB1 (0.39) MAPTHSD17B10ALDH1A1RXFP1POLB
SCHEMBL823751 0.82 TAAR1 (0.43) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL826077 0.82 TAAR1 (0.43) PDE4APDE4BPDE4CPDE4DMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143394-B2 Pyrido(3,2-d)pyrimidines useful for treating viral infections GILEAD SCIENCES, INC. (US) 2012-03-27 US disclosed
US-8143394-B2 Pyrido(3,2-d)pyrimidines useful for treating viral infections GILEAD SCIENCES, INC. (US) 2012-03-27 US disclosed
US-8143394-B2 Pyrido(3,2-d)pyrimidines useful for treating viral infections GILEAD SCIENCES, INC. (US) 2012-03-27 US disclosed
US-20090324543-A1 PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS GILEAD SCIENCES, INC (US) 2009-12-31 US disclosed
US-20090324543-A1 PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS GILEAD SCIENCES, INC (US) 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090324543-A1 PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS PNPO, DPYD, PLPBP PDE4A 1300/4885PDE4B 1595/4885PDE4C 1685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.